• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

11
2
2
2
1

COUNTRY

2
1

PRICE

1
6
9
18

PUBLISHED

0
1
5
18

PRODUCT TYPE

18

Bladder Cancer

(18 Products)

Bladder cancer is the fourth most common cancer among males in the US and due to its prevalence among the over 65s, diagnoses are set to increase in ageing populations worldwide. Reports in the Bladder Cancer section cover a variety of areas, such as the latest R&D and clinical trials taking place in universities, hospitals and other research centres around the world. Explore epidemiology, unmet needs, drug development (cytotoxic, immunotherapy agents, etc.), supply & demand, business development strategies, licensing and partnership opportunities, and the activities of key industry players such as Bristol-Myers Squibb, Spectrum Pharmaceuticals, Bioniche Life Sciences, Endo Pharmaceuticals, Eli Lilly and Sanofi-Aventis. Show Less Read more

Bladder Cancer: Disease and Pipeline Analysis

This report offers an in-depth market and pipeline analysis of the bladder cancer market. This unique therapeutic assessment provides an overview of the current and future bladder cancer clinical development...

March 2014
FROM

Bladder Cancer Treatment Drugs Markets in China

China's demand for Bladder Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a...

June 2015
FROM

Bladder Cancer Drug Pathway Analyzer 2015

Extra value: One year of free online updates included with this product There are today at least 110 targeted molecular therapies known to affect more than 216 specific intracellular signaling pathways...

January 2015
FROM
Global Bladder Cancer Epidemiology and Patient Flow Analysis - 2015 Global Bladder Cancer Epidemiology and Patient Flow Analysis - 2015 - Product Thumbnail Image

Global Bladder Cancer Epidemiology and Patient Flow Analysis - 2015

The author announced the results of its Bladder Cancer patient population study in a new report ‘Global Bladder Cancer Epidemiology and Patient Flow Analysis - 2015’. The report provides insights into...

January 2015
FROM

Bladder Cancer Drug Pipeline Update 2015

According to the American Cancer Society, bladder cancer is the 6th most common cancer in the U.S. Bladder cancer occurs among both men and women. When found and treated early, the 5 year survival rate...

January 2015
FROM
Bladder cancer Pipeline Highlights - 2015 Bladder cancer Pipeline Highlights - 2015 - Product Thumbnail Image

Bladder cancer Pipeline Highlights - 2015

The latest report Bladder cancer Pipeline Highlights – 2015, provides most up-to-date information on key pipeline molecules in the global Bladder cancer market. It covers emerging therapies for Bladder...

November 2014
FROM

OpportunityAnalyzer: Bladder Cancer - Opportunity Analysis and Forecasts to 2017

Bladder cancer is a urologic malignancy arising from the epithelial lining of the urinary bladder Although it is the ninth most common cancer worldwide in men and women, with the highest recurrence...

December 2013
FROM

EpiCast Report: Bladder Cancer - Epidemiology Forecast to 2022

EpiCast Report: Bladder Cancer - Epidemiology Forecast to 2022 Summary With more than 12 million new cases occurring worldwide each year, bladder cancer is estimated to be the ninth most common cancer,...

November 2013
FROM
Bladder Cancer – Executive Market Summary 2013 Bladder Cancer – Executive Market Summary 2013 - Product Thumbnail Image

Bladder Cancer – Executive Market Summary 2013

The Bladder Cancer Executive Market Summary 2013 provides an overview of the disease and related conditions, with incidence, prevalence, and mortality numbers and percentages for major countries worldwide,...

May 2013
FROM
Global Bladder Cancer Pipeline Capsule - 2013 Global Bladder Cancer Pipeline Capsule - 2013 - Product Thumbnail Image

Global Bladder Cancer Pipeline Capsule - 2013

Fore Pharma’s latest report ‘Global Bladder Cancer Pipeline Capsule – 2013’ provides up-to-date information on key Research and Development (R&D) activities in the global bladder cancer market. It covers...

April 2013
FROM

Bladder Cancer – Executive Market Summary 2011

Executive Market Summaries were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format These reports are prepared by the senior market...

May 2012
FROM
01 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities 01 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities - Product Thumbnail Image

01 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

This report includes details on 47 emerging medical technology companies that have been identified by LSI's in-house research team in January 2012. All companies include technology, market(s), key...

January 2012
FROM

Bladder Cancer Global Clinical Trials Review, H2, 2011

Bladder Cancer Global Clinical Trials Review, H2, 2011 Summary GlobalData's clinical trial report, “Bladder Cancer Global Clinical Trials Review, H2, 2011" provides data on the Bladder Cancer clinical...

August 2011
FROM
2011 O.U.S. Markets For External Radiation Therapy 2011 O.U.S. Markets For External Radiation Therapy - Product Thumbnail Image

2011 O.U.S. Markets For External Radiation Therapy

2011 O U S Markets For External Radiation Therapy is a comprehensive market intelligence solution designed for senior executives who are looking for: - High quality, granular, deeply segmented data...

May 2011
FROM
2011 Global Markets for External Radiation Therapy 2011 Global Markets for External Radiation Therapy - Product Thumbnail Image

2011 Global Markets for External Radiation Therapy

2011 Global Markets for External Radiation Therapy is a comprehensive market intelligence solution designed for senior executives who are looking for: - High quality, granular, deeply segmented data...

May 2011
FROM
2011 U.S. Markets for External Radiation Therapy 2011 U.S. Markets for External Radiation Therapy - Product Thumbnail Image

2011 U.S. Markets for External Radiation Therapy

2011 U S Markets for External Radiation Therapy is a comprehensive market intelligence solution designed for senior executives who are looking for: - High quality, granular, deeply segmented data -...

May 2011
FROM

Bladder Cancer Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Bladder Cancer Therapeutics in US$ Million. The report provides separate comprehensive analytics for US, Japan, Europe, and Rest of World. Annual estimates...

October 2010
FROM

European Bladder Cancer Therapeutics Markets

This Frost & Sullivan research titled European Bladder Cancer Therapeutics Markets presents a concise analysis of the market that includes challenges, factors driving growth and the revenue forecasts...

August 2007
FROM
Loading Indicator

Our Clients

Novartis AG Roche Diagnostics Ltd. Genentech, Inc. Photocure ASA Bristol-Myers Squibb Eli Lilly and Company